| Smiles |
O=C3(OC(C=2(N=C(C(C=CC1(=CC=CC=C1))C)OC=2))C(C(=O)NC(C(=O)O)CC(=O)N(C(C(=O)N(C(C(NC(C(N5(C(C(NC3C(OC)C4(=CC=CC=C4))=O)CCC5))=O)CC(=O)N)=O)C(CC)C)C)C(C)C)C)C)
|
| CAS number |
141266-02-6
|
| Polar Surface Area |
290,18
|
| calculated LogS |
-4,706
|
| Molweight |
1027,18
|
| calculated LogP |
1,3705
|
| H-Acceptors |
21
|
| H-Donors |
5
|
| Ro5 violations |
2
|
| Druglikeness |
-0,49328
|
| DrugScore |
0,1608836
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
high
|
| Irritant |
none
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,2001
|
| Rat Acute Toxicity |
3,1717
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
-0,1133
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Inhibitor
|
| P-glycoprotein Inhibitor2 |
Inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,6658
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB-
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
Low HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA+
|
| Structure |
141266-02-6
|
